pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·8h ago·1 min read
save

Developing a Global Clinical Trial Strategy for Emerging Biotechs

Discussing how small biotechs can accelerate clinical development with fit-for-purpose global clinical trial strategies.

Aug 19, 2026·read at Fierce Biotech ↗

Partner Content Developing a Global Clinical Trial Strategy for Emerging Biotechs By Andrew Goldstein Aug 19, 2026 9:45am CMO Multimedia webcast Partner Content This podcast feature a panel discussion from the 2026 Chief Medical Officer Summit 360°, biotech CMOs and executives from CROs and consultancies. Together they discuss how small biotechs can accelerate clinical development with fit-for-purpose global clinical trial strategies. Specifically: The benefits and challenges of running clinical trials in different regionsWhen and at which phases to run clinical trials in different countriesBridging data for approval applicationsManaging global clinical trials in areas with different cultures and health systems To learn more about the Chief Medical Officer Summit 360°, please visit CMOSummit360.com.

CMO Multimedia webcast Partner Content

source

Reporting by Fierce Biotech.

read at Fierce Biotech ↗
117 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Approval

related stories

  • Apr 28STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic accessSTAT
  • Apr 28Incyte claims double Phase 3 win in vitiligo, will file for approvalEndpoints
  • Apr 28FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ resultsBioPharma Dive
  • Apr 28STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data neededSTAT
  • Apr 28FDA claims trial 'manipulation' tainted approval of ChemoCentryx drugEndpoints